HIV Infection Control and Rights Protection for People Living with HIV Act Article 16

PLHIV shall visit medical care institutions designated by the central competent authorities for treatment, regular examinations and testing.PLHIV who refuse the treatment, regular examinations and testing provided for in the preceding Paragraph may be required to attend instructional training or receive supervised education by the municipal, county and city competent authorities.For PLHIV, in the two years from their confirmed diagnosis and medication initiation, the following expenses shall be fully subsidized by the central competent authorities:1. HIV treatment-related expenses including diagnostic fees during outpatient and inpatient care.2. Expenses for antiretroviral medications.3. Pharmaceutical service fees for antiretroviral medications.4. Laboratory service fees for tests on HIV viral load and CD4 cell count.5. Other items designated by the central competent authorities.Of the expenses mentioned in the preceding Paragraph, after the two-year period following confirmed diagnosis and medication initiation, the central competent authority shall budget for copayments by PLHIV as well as for tests and medications not covered by the National Health Insurance.The regulations concerning eligibility, procedures, annulment, and other matters related to the subsidies mentioned in the preceding two Paragraphs shall be formulated by the central competent authority.
中文原文 人類免疫缺乏病毒傳染防治及感染者權益保障條例第16條
感染者應至中央主管機關指定之醫療機構接受人類免疫缺乏病毒感染治療及定期檢查、檢驗。
感染者拒絕前項規定之治療及定期檢查、檢驗者,直轄市、縣(市)主管機關得施予講習或輔導教育。
感染者自確診開始服藥後二年內,以下費用由中央主管機關予以全額補助:
一、人類免疫缺乏病毒門診及住院診察費等治療相關之醫療費用。
二、抗人類免疫缺乏病毒之藥品費。
三、抗人類免疫缺乏病毒藥品之藥事服務費。
四、病毒負荷量檢驗及感染性淋巴球檢驗之檢驗費。
五、其他經中央主管機關指定之項目。
前項費用於感染者確診開始服藥二年後,全民健康保險保險對象應自行負擔之費用及依全民健康保險法未能給付之檢驗及藥物,應由中央主管機關編列預算支應之。
前兩項補助之對象、程序、廢止及其他應遵行事項之辦法,由中央主管機關定之。

English translation for reference only; the Chinese text prevails. Not legal advice.